Effect of Vitamin B 12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trial

Clinical studies have shown that hyper-homocysteinemia is a potent independent risk factor for cardiovascular diseases, and many different methods have been investigated for lowering it in hemodialysis (HD) patients. Our study investigated the effect of Vitamin B 12 supplementation on serum homocyst...

Full description

Bibliographic Details
Main Authors: Ali Tayebi, Vajihe Biniaz, Samira Savari, Abbas Ebadi, Mahdi Sadeghi Shermeh, Behzad Einollahi, Abolfazl Rahimi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2016;volume=27;issue=2;spage=256;epage=262;aulast=Tayebi
id doaj-652bae06435d4f11806e6c7be0fb32aa
record_format Article
spelling doaj-652bae06435d4f11806e6c7be0fb32aa2020-11-24T21:51:55ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422016-01-0127225626210.4103/1319-2442.178255Effect of Vitamin B 12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trialAli TayebiVajihe BiniazSamira SavariAbbas EbadiMahdi Sadeghi ShermehBehzad EinollahiAbolfazl RahimiClinical studies have shown that hyper-homocysteinemia is a potent independent risk factor for cardiovascular diseases, and many different methods have been investigated for lowering it in hemodialysis (HD) patients. Our study investigated the effect of Vitamin B 12 supplementation on serum homocysteine levels in these patients. This randomized trial was conducted on 140 HD patients. They were randomly distributed by lottery method into two groups: intervention and control. In the intervention group, 100 μg/mL of Vitamin B 12 was intravenously injected two times a week, for eight weeks. No intervention was performed in the control group. Serum levels of homocysteine, hemoglobin (Hb), and hematocrit (Hct) were measured at the beginning and again after eight weeks (2 months) of treatment. About 91% of the patients had hyperhomocysteinemia (serum homocysteine >15 μmol/L). The median baseline levels of serum homocysteine in the intervention and control groups were 31.9 and 26.9 μmol/L, respectively (P = 0.1). After eight weeks, the median homocysteine level reduced significantly in the Vitamin B 12 group to 22.2 versus 28.4 μmol/L in control group (P = 0.006). The mean Hb and Hct also changed significantly during our study (12.3 vs. 11.4 g/dL; P = 0.003 and 37.9 vs. 35.3%; P = 0.02, respectively). Our results demonstrated the existence of a statistical negative relationship between Vitamin B 12 and serum levels of homocysteine. Detailed investigations with larger sample sizes and longer-term use of Vitamin B 12 are recommended.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2016;volume=27;issue=2;spage=256;epage=262;aulast=Tayebi
collection DOAJ
language English
format Article
sources DOAJ
author Ali Tayebi
Vajihe Biniaz
Samira Savari
Abbas Ebadi
Mahdi Sadeghi Shermeh
Behzad Einollahi
Abolfazl Rahimi
spellingShingle Ali Tayebi
Vajihe Biniaz
Samira Savari
Abbas Ebadi
Mahdi Sadeghi Shermeh
Behzad Einollahi
Abolfazl Rahimi
Effect of Vitamin B 12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trial
Saudi Journal of Kidney Diseases and Transplantation
author_facet Ali Tayebi
Vajihe Biniaz
Samira Savari
Abbas Ebadi
Mahdi Sadeghi Shermeh
Behzad Einollahi
Abolfazl Rahimi
author_sort Ali Tayebi
title Effect of Vitamin B 12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trial
title_short Effect of Vitamin B 12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trial
title_full Effect of Vitamin B 12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trial
title_fullStr Effect of Vitamin B 12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trial
title_full_unstemmed Effect of Vitamin B 12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trial
title_sort effect of vitamin b 12 supplementation on serum homocysteine in patients undergoing hemodialysis: a randomized controlled trial
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Kidney Diseases and Transplantation
issn 1319-2442
publishDate 2016-01-01
description Clinical studies have shown that hyper-homocysteinemia is a potent independent risk factor for cardiovascular diseases, and many different methods have been investigated for lowering it in hemodialysis (HD) patients. Our study investigated the effect of Vitamin B 12 supplementation on serum homocysteine levels in these patients. This randomized trial was conducted on 140 HD patients. They were randomly distributed by lottery method into two groups: intervention and control. In the intervention group, 100 μg/mL of Vitamin B 12 was intravenously injected two times a week, for eight weeks. No intervention was performed in the control group. Serum levels of homocysteine, hemoglobin (Hb), and hematocrit (Hct) were measured at the beginning and again after eight weeks (2 months) of treatment. About 91% of the patients had hyperhomocysteinemia (serum homocysteine >15 μmol/L). The median baseline levels of serum homocysteine in the intervention and control groups were 31.9 and 26.9 μmol/L, respectively (P = 0.1). After eight weeks, the median homocysteine level reduced significantly in the Vitamin B 12 group to 22.2 versus 28.4 μmol/L in control group (P = 0.006). The mean Hb and Hct also changed significantly during our study (12.3 vs. 11.4 g/dL; P = 0.003 and 37.9 vs. 35.3%; P = 0.02, respectively). Our results demonstrated the existence of a statistical negative relationship between Vitamin B 12 and serum levels of homocysteine. Detailed investigations with larger sample sizes and longer-term use of Vitamin B 12 are recommended.
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2016;volume=27;issue=2;spage=256;epage=262;aulast=Tayebi
work_keys_str_mv AT alitayebi effectofvitaminb12supplementationonserumhomocysteineinpatientsundergoinghemodialysisarandomizedcontrolledtrial
AT vajihebiniaz effectofvitaminb12supplementationonserumhomocysteineinpatientsundergoinghemodialysisarandomizedcontrolledtrial
AT samirasavari effectofvitaminb12supplementationonserumhomocysteineinpatientsundergoinghemodialysisarandomizedcontrolledtrial
AT abbasebadi effectofvitaminb12supplementationonserumhomocysteineinpatientsundergoinghemodialysisarandomizedcontrolledtrial
AT mahdisadeghishermeh effectofvitaminb12supplementationonserumhomocysteineinpatientsundergoinghemodialysisarandomizedcontrolledtrial
AT behzadeinollahi effectofvitaminb12supplementationonserumhomocysteineinpatientsundergoinghemodialysisarandomizedcontrolledtrial
AT abolfazlrahimi effectofvitaminb12supplementationonserumhomocysteineinpatientsundergoinghemodialysisarandomizedcontrolledtrial
_version_ 1725877778265407488